What this means
This trial is still recruiting people, so no results are available yet. It aims to find how much of a digital program is needed to help thinking skills.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 60–99
- Where
- 1 site, including California
The science
- Registered title
- Enhancing Attention and Wellbeing Using Digital Therapeutics
- Trial ID
- NCT06397469 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Aging, MCI, Cognitive Decline
- What is tested
- MediTrain, Worder
- Sponsor
- University of California, San Francisco
- Ages
- 60 Years to 99 Years
- Dates
- First posted May 3, 2024 · updated Aug 24, 2026
Registry summary
The goals of the proposed research are to first determine the minimal and/or optimal dose of a digital intervention required for cognitive enhancement, and then to examine the impact of several potential moderators of treatment effects (i.e., cognitive decline, AD polygenic hazard score, cardiovascular risk, and race/ethnicity). This knowledge gained from his high-impact study with transform the field of cognitive interventions, paving the way for a precision medicine model for cognitive enhancing interventions that improve quality of life for older adults and individuals with cognitive deficits at risk of developing dementia.
Sites (1)
- University of California San Francisco, San Francisco, California, United States